Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3564-3569

  Pritchard, Jane ^a,b   Tsui, Shanli ^a,b   Horst, Noah ^c   Cruikshank, William W ^c   Smith, Terry J ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOATTRACTANT; DEXAMETHASONE; IMMUNOGLOBULIN G; INTERLEUKIN 16; RANTES; RAPAMYCIN; SOMATOMEDIN C RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; GRAVES DISEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BLOCKING; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE;

EID: 4344640489     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3564     Document Type: Article

References (48)

1. Müller-Ladner, U., R. E. Gay, and S. Gay. 1997. Structure and function of synoviocytes. In Arthritis and Related Conditions, Vol. 1. W. J. Koopman, ed. Williams and Wilkins, Baltimore, p. 243.
2. Smith, T. J., R. S. Bahn, and C. A. Gorman. 1989. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr. Rev. 10:366.
3. Sempowski, G. D., J. Rozenblit, T. J. Smith, and R. P. Phipps. 1998. Human orbital fibroblasts are activated through CD40 to induce pro-inflammatory cytokine production. Am. J. Physiol.: Cell Physiol. 274:C707.
4. Yellin, M. J., S. Winikoff, S. M. Fortune, D. Baum, M. K. Crow, S. Lederman, and L. Chess. 1995. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J. Leukocyte Biol. 58:209.
5. Pap, T., U. Müllerr-Ladner, R. E. Gay, and S. Gay. 2000. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2:361.
6. Sweeney, S. E., and G. S. Firestein. 2004. Rheumatoid arthritis: regulation of synovial inflammation. Int. J. Biochem. Cell Biol. 36:372.
7. + T lymphocytes in rheumatoid arthritis. Eur. J. Immunol. 28:2661.
8. Sciaky, D., W. Brazer, D. M. Center, W. W. Cruikshank, and T. J. Smith. 2000. Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J. Immunol. 164:3806.
9. Kaufmann, J., S. Franke, R. Kientsch-Engel, P. Oelzner, G. Hein, and G. Stein. 2001. Correlation of circulating interleukin 16 with proinflammatory cytokines in patients with rheumatoid arthritis. Rheumatology 40:474.
10. Volin, M. V., M. R. Shah, M. Tokuhira, G. K. Haines III, J. M. Woods, and A. E. Koch. 1998. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin. Immunol. Immunopathol. 89:44.
11. Center, D. M., H. Kornfeld, and W. W. Cruikshank. 1997. Interleukin-16. Int. J. Biochem. Cell Biol. 29:1231.
12. Klimiuk, P. A., J. J. Goronzy, and C. M. Weyand. 1999. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. J. Immunol. 162:4293.
13. Schall, T. J., K. Bacon, K. J. Toy, and D. V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669.
14. Rot, A., M. Krieger, T. Brunner, S. C. Bischoff, T. J. Schall, and C. A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489.
15. Rathanaswami, P., M. Hachicha, M. Sadick, T. J. Schall, and S. R. McColl. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts: differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J. Biol. Chem. 268:5834.
16. Pritchard, J., N. Horst, W. Cruikshank, and T. J. Smith. 2002. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J. Immunol. 168:942.
17. Pritchard, J., R. Han, N. Horst, W. W. Cruikshank, and T. J. Smith. 2003. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J. Immunol. 170:6348.
18. Prabhakar, B. S., R. S. Bahn, and T. J. Smith. 2003. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr. Rev. 24:802.
19. Yoshimoto, T., C.-R. Wang, T. Yoneto, A. Matsuzawa, W. W. Cruikshank, and H. Nariuchi. 2000. Role of IL-16 in delayed-type hypersensitivity reaction. Blood 95:2869.
20. Smith, T. J., R. S. Bahn, and C. A. Gorman. 1989. Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts. J. Clin. Endocrinol. Metab. 69:1019.
21. Smith, T. J., L. Koumas, A. Gagnon, A. Bell, G. D. Sempowski, R. P. Phipps, and A. Sorisky. 2002. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 87:385.
22. Fassbender, H. G. 1983. Histomorphologic basis of articular cartilage destruction in rheumatoid arthritis. Collagen Relat. Res. 3:141.
23. Rosenfeld, R. G., and L. A. Dollar. 1982. Characterization of the somatomedin C/insulin like growth factor 1 (SM-C/IGF-1) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF-1 and insulin. J. Clin. Endocrinol. Metab. 55:434.
24. Butler, A. A., S. Yakar, I. H. Gewolb, M. Karas, Y. Okubo, and D. LeRoith. 1998. Insulin-like growth factor-I receptor signal transduction at the interface between physiology and cell biology. Comp. Biochem. Physiol. Biochem. Mol. Biol. 121:19.
25. Li, S. L., J. Kato, I. B. Paz, J. Kasuya, and Y. Fujita-Yamaguchi. 1993. Two new monoclonal antibodies against the α-subunit of human insulin-like growth factor-I receptor. Biochem. Biophys. Res. Commun. 196:92.
26. Reiss, K., C. D'Ambrosio, X. Tu, C. Tu, and R. Baserga. 1998. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin. Cancer Res. 4:2647.
27. Francis, G. L., M. Ross, F. J. Ballard, S. J. Milner, C. Senn, K. A. McNeil, J. C. Wallace, R. King, and J. R. Wells. 1992. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J. Mol. Endocrinol. 8:213.
28. Bayne, M. L., J. Applebaum, G. G. Chicchi, R. E. Miller, and M. A. Cascieri. 1990. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth receptor. J. Biol. Chem. 265:15648.
29. Gingras, A.-C., B. Raught, and N. Sonenberg. 2001. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:807.
30. Peruzzi, F., M. Prisco, M. Dews, P. Salomoni, E. Grassilli, G. Romano, B. Calabretta, and R. Baserga. 1999. Multiple signalling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol. Cell. Biol. 19:7203.
31. + T cells by interleukin 16 and interleukin 2. J. Immunol. 160:2115.
32. + T cells. Immunology 96:215.
33. Mashikian, M. V., T. C. Ryan, A. Seman, W. Brazer, D. M. Center, and W. W. Cruikshank. 1999. Reciprocal desensitization of CCR5 and CD4 is mediated by IL-16 and macrophage-inflammatory protein-1β, respectively. J. Immunol. 163:3123.
34. lck enzymatic activity. J. Immunol. 165:6356.
35. Nanki, T., K. Nagasaka, K. Hayashida, Y. Saita, and N. Miyasaka. 2001. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J. Immunol. 167:5381.
36. Lynch, E. A., C. A. W. Heijens, N. F. Horst, D. M. Center, and W. W. Cruikshank. 2003. Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5. J. Immunol. 171:4965.
37. Smith, T. J. 2003. The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation. Autoimmunity 36:409.
38. Wang, H.-S., H. J. Cao, V. D. Winn, L. J. Rezanka, Y. Frobert, C. H. Evans, D. Sciaky, D. A. Young, and T. J. Smith. 1996. Leukoregulin induction of prostaglandin endoperoxide H synthase-2 in human orbital fibroblasts: an in vitro model for connective tissue inflammation. J. Biol. Chem. 271:22718.
39. Young, D. A., C. H. Evans, and T. J. Smith. 1998. Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical-site-restricted cytokine-target cell interactions. Proc. Natl. Acad. Sci. USA 95:8904.
40. Cao, H. J., H.-S. Wang, Y. Zhang, H.-Y. Lin, R. P. Phipps, and T. J. Smith. 1998. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression: insights into potential pathogenic mechanisms of thyroid associated ophthalmopathy. J. Biol. Chem. 273:29615.
41. Weetman, A. P. 2001. Determinants of autoimmune thyroid disease. Nat. Immunol. 2:769.
42. Magnus, J. H., T. Birketvedt, and H. J. Haga. 1995. A prospective evaluation of antithyroid antibody prevalence in 100 patients with rheumatoid arthritis. Scand. J. Rheumatol. 24:180.
43. Shiroky, J. B., M. Cohen, M. L. Ballachey, and C. Neville. 1993. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann. Rheum. Dis. 52:454.
44. O'Toole, E. A., L. L. Mak, J. Guitart, D. T. Woodley, T. Hashimoto, M. Amagai, and L. S. Chan. 2000. Induction of keratinocyte IL-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin. Exp. Immunol. 119:217.
45. Heufelder, A. E., and R. S. Bahn. 1992. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur. J. Clin. Invest. 22:529.
46. Rotella, C. M., J. Zonefrati, R. Toccafondi, W. A. Valente, and L. D. Kohn. 1986. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J. Clin. Endocrinol. Metab. 62:357.
47. Davies, T. F. 1996. Graves' disease. In The Thyroid, 7th Ed. L. E. Braverman and R. D. Utiger, eds. Lippincott-Raven Publishers, Philadelphia, p. 525.
48. Reyes-Reyna, S., T. Stegall, and K. A. Krolick. 2002. Muscle responds to an antibody reactive with the acetylcholine receptor by up-regulating monocyte chemoattactant protein 1: a chemokine with the potential to influence the severity and course of experimental myasthenia gravis. J. Immunol. 169:1579.